微创心通医疗科技有限公司（02160）于2026年2月5日发布2026年1月月报。报告期为2026年1月1日至2026年1月31日。
报告显示，公司法定/注册股本维持在10,000,000,000股，面值0.000005美元，注册股本总额50,000美元。本月无注册股本变动。
截至1月底，公司普通股已发行股份数由上月的6,366,554,182股增至6,366,557,195股，合计增加3,013股；库存股份数为0，较上月无变化。公司声明，截至报告期末，符合香港联交所对于公众持股量的要求。
根据公告，当月主要变动来自于股份期权的行使。公司购回及注销方面未有新增活动，总股本随股份期权行使而上调。公司确认遵守香港联交所《上市规则》及相关法律法规。
本次月报由联席公司秘书李香梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.